Trials / Conditions / Spinocerebellar Ataxia Type 1

Spinocerebellar Ataxia Type 1

13 registered clinical trials studyying Spinocerebellar Ataxia Type 1 — 3 currently recruiting.

Status	Trial	Sponsor	Phase
Not Yet Recruiting	Umbilical Cord Mesenchymal Stem Cells Therapy (19#iSCLife®-SA) for Patients With Spinocerebellar Ataxia NCT03378414	Sclnow Biotechnology Co., Ltd.	Phase 2
Recruiting	A Safety and Pharmacokinetics Trial of VO659 in SCA1, SCA3 and HD NCT05822908	Vico Therapeutics B. V.	Phase 1 / Phase 2
Active Not Recruiting	Priming Motor Learning Through Exercise in People With Spinocerebellar Ataxia NCT05826171	Teachers College, Columbia University	N/A
Withdrawn	Study of CAD-1883 for Spinocerebellar Ataxia NCT04301284	Cadent Therapeutics	Phase 2
Completed	Instrumented Data Exchange for Ataxia Study NCT04268147	University of Chicago	—
Active Not Recruiting	Troriluzole in Adult Participants With Spinocerebellar Ataxia NCT03701399	Biohaven Pharmaceuticals, Inc.	Phase 3
Completed	Cerebello-Spinal tDCS as Rehabilitative Intervention in Neurodegenerative Ataxia NCT04153110	Azienda Socio Sanitaria Territoriale degli Spedali Civili di Brescia	N/A
Unknown	Clinical Trial Readiness for SCA1 and SCA3 NCT03487367	The Methodist Hospital Research Institute	—
Active Not Recruiting	Open Pilot Trial of BHV-4157 NCT03408080	University of California, Los Angeles	Phase 3
Completed	Rehabilitative Trial With Cerebello-Spinal tDCS in Neurodegenerative Ataxia NCT03120013	Azienda Socio Sanitaria Territoriale degli Spedali Civili di Brescia	N/A
Completed	Biomarkers in Autosomal Dominant Cerebellar Ataxia NCT01470729	Assistance Publique - Hôpitaux de Paris	—
Recruiting	Rare Disease Patient Registry & Natural History Study - Coordination of Rare Diseases at Sanford NCT01793168	Sanford Health	—
Unknown	Natural History Study of and Genetic Modifiers in Spinocerebellar Ataxias NCT01060371	University of Florida	—